Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Corrigendum to "Efficacy and safety of basal insulin degludec 100 IU/mL versus glargine 300 IU/mL for type 1 diabetes: The single-center INEOX randomized controlled trial" [Diabetes Res. Clin. Pract. 196 (2023) 110238].
Ruiz-de-Adana MS, Domínguez ME, Morillas V, Colomo N, Vallejo-Mora R, Guerrero M, García-Escobar E, Carreira M, Romero-Zerbo Y, Linares F, González-Mariscal I, Bermúdez-Silva FJ, Olveira G, Rojo-Martínez G. Ruiz-de-Adana MS, et al. Among authors: gonzalez mariscal i. Diabetes Res Clin Pract. 2024 Apr;210:111620. doi: 10.1016/j.diabres.2024.111620. Epub 2024 Mar 21. Diabetes Res Clin Pract. 2024. PMID: 38514300 No abstract available.
Corrigendum to "Beta cell specific cannabinoid 1 receptor deletion counteracts progression to hyperglycemia in non-obese diabetic mice" [Mol Metab 82 (2024 April) 101906].
Aseer KR, Mazucanti CH, O'Connell JF, González-Mariscal I, Verma A, Yao Q, Dunn C, Liu QR, Egan JM, Doyle ME. Aseer KR, et al. Among authors: gonzalez mariscal i. Mol Metab. 2024 Apr;82:101917. doi: 10.1016/j.molmet.2024.101917. Epub 2024 Mar 16. Mol Metab. 2024. PMID: 38499184 Free PMC article. No abstract available.
Au@16-pH-16/miR-21 mimic nanosystem: An efficient treatment for obesity through browning and thermogenesis induction.
Lhamyani S, Gentile AM, Mengual-Mesa M, Grueso E, Giráldez-Pérez RM, Fernandez-Garcia JC, Vega-Rioja A, Clemente-Postigo M, Pearson JR, González-Mariscal I, Olveira G, Bermudez-Silva FJ, El Bekay R. Lhamyani S, et al. Among authors: gonzalez mariscal i. Biomed Pharmacother. 2024 Feb;171:116104. doi: 10.1016/j.biopha.2023.116104. Epub 2024 Jan 9. Biomed Pharmacother. 2024. PMID: 38198956 Free article.
Efficacy and safety of basal insulin degludec 100 IU/mL versus glargine 300 IU/mL for type 1 diabetes: The single-center INEOX randomized controlled trial.
Ruiz de Adana MS, Domínguez ME, Morillas V, Colomo N, Vallejo-Mora R, Guerrero M, García-Escobar E, Carreira M, Romero-Zerbo Y, Linares F, González-Mariscal I, Bermúdez-Silva FJ, Olveira G, Rojo-Martínez G. Ruiz de Adana MS, et al. Among authors: gonzalez mariscal i. Diabetes Res Clin Pract. 2023 Feb;196:110238. doi: 10.1016/j.diabres.2023.110238. Epub 2023 Jan 5. Diabetes Res Clin Pract. 2023. PMID: 36610544 Clinical Trial.
Abnormal cannabidiol ameliorates inflammation preserving pancreatic beta cells in mouse models of experimental type 1 diabetes and beta cell damage.
González-Mariscal I, Pozo-Morales M, Romero-Zerbo SY, Espinosa-Jimenez V, Escamilla-Sánchez A, Sánchez-Salido L, Cobo-Vuilleumier N, Gauthier BR, Bermúdez-Silva FJ. González-Mariscal I, et al. Biomed Pharmacother. 2022 Jan;145:112361. doi: 10.1016/j.biopha.2021.112361. Epub 2021 Dec 3. Biomed Pharmacother. 2022. PMID: 34872800 Free article.
(+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB1R antagonist/CB2R agonist that prevents diabetic nephropathy in mice.
González-Mariscal I, Carmona-Hidalgo B, Winkler M, Unciti-Broceta JD, Escamilla A, Gómez-Cañas M, Fernández-Ruiz J, Fiebich BL, Romero-Zerbo SY, Bermúdez-Silva FJ, Collado JA, Muñoz E. González-Mariscal I, et al. Pharmacol Res. 2021 Jul;169:105492. doi: 10.1016/j.phrs.2021.105492. Epub 2021 May 19. Pharmacol Res. 2021. PMID: 34019978
The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease.
Romero-Zerbo SY, García-Fernández M, Espinosa-Jiménez V, Pozo-Morales M, Escamilla-Sánchez A, Sánchez-Salido L, Lara E, Cobo-Vuilleumier N, Rafacho A, Olveira G, Rojo-Martínez G, Gauthier BR, González-Mariscal I, Bermúdez-Silva FJ. Romero-Zerbo SY, et al. Among authors: gonzalez mariscal i. Front Endocrinol (Lausanne). 2020 Mar 6;11:103. doi: 10.3389/fendo.2020.00103. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32210914 Free PMC article.
30 results